Vitamin C enhances cisplatin sensitivity in bladder cancer via 5hmC-mediated epigenetic modulation of ATF4
Chunru Xu, Wenwei Ying, Yuhui He, Yucai Wu, Tai Tian, Jilong Zhang, Shiming He, Cuijian Zhang, Xuesong Li, Yanqing Gong · 2025
Read Vitamin C enhances cisplatin sensitivity in bladder cancer via 5hmC-mediated epigenetic modulation of ATF4 by Chunru Xu, Wenwei Ying, Yuhui He, Yucai Wu, Tai Tian, Jilong Zhang, Shiming He, Cuijian Zhang, Xuesong Li, Yanqing Gong (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12717703.txt.
Description
Chunru Xu and co-authors show that vitamin C can make bladder cancer cells respond again to a standard drug, in a 2025 study. The drug, cisplatin, often stops working as tumors grow resistant. In samples from thirty-six patients, low levels of a DNA mark called 5hmC in tumor tissue before treatment tracked with resistance and with shorter time before the cancer grew again.
In lab-grown resistant cells, vitamin C restored the mark by switching on enzymes called TET, slowed growth, and restored drug response. A blocker of those enzymes undid the effect. Gene tests traced the action to a stress protein, ATF4, whose level the vitamin lowered. Cutting ATF4 on its own also restored drug response.
Catalog record
| CREATOR | Chunru Xu, Wenwei Ying, Yuhui He, Yucai Wu, Tai Tian, Jilong Zhang, Shiming He, Cuijian Zhang, Xuesong Li, Yanqing Gong |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |